Bharat Biotech
Covaxin Shows Overall Efficacy Of 77.8% Against Symptomatic COVID-19 Cases
Bharat Biotech’s Covaxin Shows 77.8 Percent Efficacy In Phase 3 Trial
"No Newborn Calf Serum In Covaxin," Says Govt: 5 Things About The Vaccine Controversy
Biovet, Associate Firm Of Bharat Biotech, To Make Pune Plant 'Functional' By August-End
Bharat Biotech Covaxin Can Now Be Tested On Children As Young As 2-Year-Old
Who Is Dr Sumathy K? The Head – R&D Bharat Biotech Which Developed Covaxin
No Clarity on Serum Institute, Bharat Biotech's COVID-19 Vaccine Proposals Amidst Mixed Reports
India's First Indigenous COVID-19 Vaccine To Start Human Trials In July